Punag Divanji

Also affiliated with Cytel (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction”.

Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction

JAMA(2022)10.1001/jama.2022.11016

N/A

1.4DataRank · unranked

62 citations

Adriaan A. Voors, Alain Cohen‐Solal, Marco Metra, David J. Whellan, Justin A. Ezekowitz +12 more

Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2023.11.021

N/A

0.358DataRank · unranked

6 citations

Scott Solomon, Marco Metra, John J.V. McMurray, Rafael Díaz, Brian Claggett +15 more

The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2023.08.020

N/A

0.312DataRank · unranked

7 citations

John J.V. McMurray, Rafael Díaz, G. Michael Felker, Marco Metra, Scott D. Solomon +19 more

Impact of COVID-19 on Heart Failure Clinical Trials

JACC Heart Failure(2023)10.1016/j.jchf.2022.11.024

N/A

0.269DataRank · unranked

5 citations

Matthew Dimond, Mona Fiuzat, Muthiah Vaduganathan, Orly Vardeny, Punag Divanji +9 more